A possible role for systemic hypoxia in the reactive component of pulmonary hypertension in heart failure

Journal of Cardiac Failure

Volumn 19, Issue 1, 2013, Pages 50-59

  Taylor, Bryan J ^a   Mojica, Cesar R ^b   Olson, Thomas P ^a   Woods, Paul R ^a   Frantz, Robert P ^a   Johnson, Bruce D ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

arterial and venous oxygen pressure and saturation; endothelin 1; neurohormones; Transpulmonary pressure gradient

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOTHELIN 1; NEUROHORMONE; OXYGEN;

ADULT; ARTICLE; BLOOD GAS ANALYSIS; BLOOD SAMPLING; CLINICAL ARTICLE; FEMALE; HEART CATHETERIZATION; HEART FAILURE; HORMONE BLOOD LEVEL; HUMAN; HYPOXIA; LUNG ARTERY; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULMONARY HYPERTENSION;

ADULT; AGED; ANOXIA; BLOOD GAS ANALYSIS; CARDIAC CATHETERIZATION; CARDIAC OUTPUT, LOW; COHORT STUDIES; DISEASE PROGRESSION; ENDOTHELIN-1; FEMALE; HEART FAILURE; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUROTRANSMITTER AGENTS; OXYGEN; PROGNOSIS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; VASCULAR RESISTANCE;

EID: 84871854854     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2012.11.005     Document Type: Article

References (47)

1. J. Kjaergaard, D. Akkan, K.K. Iversen, E. Kjoller, L. Kober, and C. Torp-Pedersen Prognostic importance of pulmonary hypertension in patients with heart failure Am J Cardiol 99 2007 1146 1150
2. S.V. Abramson, J.F. Burke, J.J. Kelly Jr., J.G. Kitchen 3rd, M.J. Dougherty, and D.F. Yih Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy Ann Intern Med 116 1992 888 895
3. C.S. Lam, V.L. Roger, R.J. Rodeheffer, B.A. Borlaug, F.T. Enders, and M.M. Redfield Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study J Am Coll Cardiol 53 2009 1119 1126
4. V.V. McLaughlin, S.L. Archer, D.B. Badesch, R.J. Barst, H.W. Farber, and J.R. Lindner ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc; and the Pulmonary Hypertension Association J Am Coll Cardiol 53 2009 1573 1619
5. M.M. Hoeper, J.A. Barbera, R.N. Channick, P.M. Hassoun, I.M. Lang, and A. Manes Diagnosis, assessment, and treatment of nonpulmonary arterial hypertension pulmonary hypertension J Am Coll Cardiol 54 1 Suppl 2009 S85 S96
6. D.L. Moraes, W.S. Colucci, and M.M. Givertz Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management Circulation 102 2000 1718 1723
7. D. Aronson, A. Eitan, R. Dragu, and A.J. Burger Relationship between reactive pulmonary hypertension and mortality in patients with acute decompensated heart failure Circ Heart Fail 4 2011 644 650
8. J.S. Sham, B.R. Crenshaw Jr., L.H. Deng, L.A. Shimoda, and J.T. Sylvester Effects of hypoxia in porcine pulmonary arterial myocytes: roles of K(V) channel and endothelin-1 Am J Physiol Lung Cell Mol Physiol 279 2000 L262 L272
9. L.A. Shimoda, J.S. Sham, Q. Liu, and J.T. Sylvester Acute and chronic hypoxic pulmonary vasoconstriction: a central role for endothelin-1? Respir Physiol Neurobiol 132 2002 93 106
10. R.J. Cody, G.J. Haas, P.F. Binkley, Q. Capers, and R. Kelley Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure Circulation 85 1992 504 509
11. T.R. Porter, D.O. Taylor, A. Cycan, J. Fields, C.W. Bagley, and N.G. Pandian Endothelium-dependent pulmonary artery responses in chronic heart failure: influence of pulmonary hypertension J Am Coll Cardiol 22 1993 1418 1424
12. S.A. Rubin, H.V. Brown, and H.J. Swan Arterial oxygenation and arterial oxygen transport in chronic myocardial failure at rest, during exercise and after hydralazine treatment Circulation 66 1982 143 148
13. B. Herrlin, and C. Sylven Increased arterial oxygen content - an important compensatory mechanism in chronic moderate heart failure Cardiovasc Res 25 1991 384 390
14. A.L. Clark, and A.J. Coats Usefulness of arterial blood gas estimations during exercise in patients with chronic heart failure Br Heart J 71 1994 528 530
15. F. Fanfulla, A. Mortara, R. Maestri, G.D. Pinna, C. Bruschi, and F. Cobelli The development of hyperventilation in patients with chronic heart failure and Cheyne-Strokes respiration: a possible role of chronic hypoxia Chest 114 1998 1083 1090
16. M.A. Munger, E.J. Stanek, A.R. Nara, K.P. Strohl, M.J. Decker, and R.N. Nair Arterial oxygen saturation in chronic congestive heart failure Am J Cardiol 73 1994 180 185
17. D.P. Moore, A.R. Weston, J.M. Hughes, C.M. Oakley, and J.G. Cleland Effects of increased inspired oxygen concentrations on exercise performance in chronic heart failure Lancet 339 1992 850 853
18. D.C. Currow, M. Agar, J. Smith, and A.P. Abernethy Does palliative home oxygen improve dyspnoea? A consecutive cohort study Palliat Med 23 2009 309 316
19. J.M. Cranston, A. Crockett, and D. Currow Oxygen therapy for dyspnoea in adults Cochrane Database Syst Rev 2008 CD004769
20. A.P. Abernethy, C.F. McDonald, P.A. Frith, K. Clark, J.E. Herndon 2nd, and J. Marcello Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial Lancet 376 2010 784 793
21. S.D. Russell, G.M. Koshkarian, A.E. Medinger, P.E. Carson, and M.B. Higginbotham Lack of effect of increased inspired oxygen concentrations on maximal exercise capacity or ventilation in stable heart failure Am J Cardiol 84 1999 1412 1416
22. M.J. Sullivan, M.B. Higginbotham, and F.R. Cobb Increased exercise ventilation in patients with chronic heart failure: intact ventilatory control despite hemodynamic and pulmonary abnormalities Circulation 77 1988 552 559
23. G. Simonneau, I.M. Robbins, M. Beghetti, R.N. Channick, M. Delcroix, and C.P. Denton Updated clinical classification of pulmonary hypertension J Am Coll Cardiol 54 1 Suppl 2009 S43 S54
24. N. Galie, M.M. Hoeper, M. Humbert, A. Torbicki, J.L. Vachiery, and J.A. Barbera Guidelines for the diagnosis and treatment of pulmonary hypertension Eur Respir J 34 2009 1219 1263
25. T.P. Olson, R.P. Frantz, E.M. Snyder, K.A. O'Malley, K.C. Beck, and B.D. Johnson Effects of acute changes in pulmonary wedge pressure on periodic breathing at rest in heart failure patients Am Heart J 153 2007 104.e1 104.e7
26. B. Holmquist, P. Bunning, and J.F. Riordan A continuous spectrophotometric assay for angiotensin converting enzyme Anal Biochem 95 1979 540 548
27. R.O. Crapo, R.L. Jensen, M. Hegewald, and D.P. Tashkin Arterial blood gas reference values for sea level and an altitude of 1,400 meters Am J Respir Crit Care Med 160 5 Pt 1 1999 1525 1531
28. C. Raphael, C. Briscoe, J. Davies, Z. Ian Whinnett, C. Manisty, and R. Sutton Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure Heart 93 2007 476 482
29. O. Oldenburg, B. Lamp, L. Faber, H. Teschler, D. Horstkotte, and V. Topfer Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients Eur J Heart Fail 9 2007 251 257
30. Q. Liu, J.S. Sham, L.A. Shimoda, and J.T. Sylvester Hypoxic constriction of porcine distal pulmonary arteries: endothelium and endothelin dependence Am J Physiol Lung Cell Mol Physiol 280 2001 L856 L865
31. C. Sartori, L. Vollenweider, B.M. Loffler, A. Delabays, P. Nicod, and P. Bartsch Exaggerated endothelin release in high-altitude pulmonary edema Circulation 99 1999 2665 2668
32. C. de Bisschop, J.B. Martinot, G. Leurquin-Sterk, V. Faoro, H. Guenard, and R. Naeije Improvement in lung diffusion by endothelin A receptor blockade at high altitude J Appl Physiol 112 2012 20 25
33. R. Naeije, S. Huez, M. Lamotte, K. Retailleau, S. Neupane, and D. Abramowicz Pulmonary artery pressure limits exercise capacity at high altitude Eur Respir J 36 2010 1049 1055
34. P.A. Modesti, S. Vanni, M. Morabito, A. Modesti, M. Marchetta, and T. Gamberi Role of endothelin-1 in exposure to high altitude: Acute Mountain Sickness and Endothelin-1 (ACME-1) study Circulation 114 2006 1410 1416
35. I. Pham, G. Wuerzner, J.P. Richalet, S. Peyrard, and M. Azizi Endothelin receptors blockade blunts hypoxia-induced increase in PAP in humans Eur J Clin Invest 40 2010 195 202
36. V. Faoro, S. Boldingh, M. Moreels, S. Martinez, M. Lamotte, and P. Unger Bosentan decreases pulmonary vascular resistance and improves exercise capacity in acute hypoxia Chest 135 2009 1215 1222
37. T. Tsutamoto, A. Wada, Y. Maeda, T. Adachi, and M. Kinoshita Relation between endothelin-1 spillover in the lungs and pulmonary vascular resistance in patients with chronic heart failure J Am Coll Cardiol 23 1994 1427 1433
38. L.E. Spieker, V. Mitrovic, G. Noll, R. Pacher, M.R. Schulze, J. Muntwyler ET 003 Investigators Acute hemodynamic and neurohumoral effects of selective ET(A) receptor blockade in patients with congestive heart failure J Am Coll Cardiol 35 2000 1745 1752
39. J.A. Madden, M.S. Vadula, and V.P. Kurup Effects of hypoxia and other vasoactive agents on pulmonary and cerebral artery smooth muscle cells Am J Physiol 263 3 Pt 1 1992 L384 L393
40. J.M. Post, J.R. Hume, S.L. Archer, and E.K. Weir Direct role for potassium channel inhibition in hypoxic pulmonary vasoconstriction Am J Physiol 262 4 Pt 1 1992 C882 C890
41. D.N. Cornfield, T. Stevens, I.F. McMurtry, S.H. Abman, and D.M. Rodman Acute hypoxia causes membrane depolarization and calcium influx in fetal pulmonary artery smooth muscle cells Am J Physiol 266 4 Pt 1 1994 L469 L475
42. H.D. Schultz, Y.L. Li, and Y. Ding Arterial chemoreceptors and sympathetic nerve activity: implications for hypertension and heart failure Hypertension 50 2007 6 13
43. Y.L. Li, and H.D. Schultz Enhanced sensitivity of Kv channels to hypoxia in the rabbit carotid body in heart failure: role of angiotensin II J Physiol 575 Pt 1 2006 215 227
44. S. Kaab, E. Miguel-Velado, J.R. Lopez-Lopez, and M.T. Perez-Garcia Down regulation of Kv3.4 channels by chronic hypoxia increases acute oxygen sensitivity in rabbit carotid body J Physiol 566 Pt 2 2005 395 408
45. Y.F. Ding, Y.L. Li, K.G. Cornish, and H.D. Schultz Reduced blood flow in carotid arteries is a trigger contributing to peripheral chemoreflex hypersensitivity in chronic heart failure rabbits [abstract] FASEB J 21 2007 A1268
46. S. Sasayama, T. Izumi, M. Matsuzaki, A. Matsumori, H. Asanoi, and S. Momomura Improvement of quality of life with nocturnal oxygen therapy in heart failure patients with central sleep apnea Circ J 73 2009 1255 1262
47. T. Toyama, R. Seki, S. Kasama, N. Isobe, S. Sakurai, and H. Adachi Effectiveness of nocturnal home oxygen therapy to improve exercise capacity, cardiac function and cardiac sympathetic nerve activity in patients with chronic heart failure and central sleep apnea Circ J 73 2009 299 304